Koninklijke Philips (PHIA) | Financial Analysis & Statements
Koninklijke Philips N.V. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
5.1B
Gross Profit
2.3B
44.88%
Operating Income
565.0M
11.08%
Net Income
398.0M
7.81%
EPS (Diluted)
€0.42
Balance Sheet Metrics
Total Assets
26.9B
Total Liabilities
16.0B
Shareholders Equity
11.0B
Debt to Equity
1.45
Cash Flow Metrics
Operating Cash Flow
1.4B
Free Cash Flow
1.2B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Koninklijke Philips Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17.8B | 18.0B | 18.2B | 17.8B | 17.2B |
| Cost of Goods Sold | 9.8B | 10.2B | 10.7B | 10.6B | 10.0B |
| Gross Profit | 8.1B | 7.8B | 7.4B | 7.2B | 7.2B |
| Gross Margin % | 45.2% | 43.1% | 41.0% | 40.4% | 41.8% |
| Operating Expenses | |||||
| Research & Development | 1.7B | 1.7B | 1.9B | 2.1B | 1.8B |
| Selling, General & Administrative | 5.0B | 5.1B | 5.1B | 5.3B | 4.9B |
| Other Operating Expenses | -61.0M | 445.0M | 594.0M | -12.0M | -118.0M |
| Total Operating Expenses | 6.6B | 7.3B | 7.6B | 7.4B | 6.5B |
| Operating Income | 1.4B | 513.0M | -168.0M | -177.0M | 623.0M |
| Operating Margin % | 8.1% | 2.8% | -0.9% | -1.0% | 3.6% |
| Non-Operating Items | |||||
| Interest Income | 83.0M | 79.0M | 46.0M | 25.0M | 18.0M |
| Interest Expense | 294.0M | 337.0M | 306.0M | 244.0M | 164.0M |
| Other Non-Operating Income | -50.0M | -133.0M | -92.0M | -1.3B | 22.0M |
| Pre-tax Income | 1.2B | 123.0M | -526.0M | -1.7B | 509.0M |
| Income Tax | 282.0M | 963.0M | -73.0M | -113.0M | -103.0M |
| Effective Tax Rate % | 23.9% | 782.9% | 0.0% | 0.0% | -20.2% |
| Net Income | 897.0M | -698.0M | -463.0M | -1.6B | 3.3B |
| Net Margin % | 5.0% | -3.9% | -2.5% | -9.0% | 19.4% |
| Key Metrics | |||||
| EBITDA | 2.6B | 1.9B | 1.0B | 1.4B | 2.0B |
| EPS (Basic) | €0.94 | €-0.75 | €-0.47 | €-1.68 | €3.40 |
| EPS (Diluted) | €0.93 | €-0.75 | €-0.47 | €-1.68 | €3.38 |
| Basic Shares Outstanding | 948239009 | 933371000 | 991199261 | 952457436 | 976933938 |
| Diluted Shares Outstanding | 948239009 | 933371000 | 991199261 | 952457436 | 976933938 |
Income Statement Trend
Koninklijke Philips Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.8B | 2.4B | 1.9B | 1.2B | 2.3B |
| Short-term Investments | - | 2.0M | 3.0M | 11.0M | 2.0M |
| Accounts Receivable | 3.3B | 3.5B | 3.7B | 3.8B | 3.6B |
| Inventory | 2.9B | 3.2B | 3.5B | 4.0B | 3.4B |
| Other Current Assets | -5.0M | -1.0M | - | - | - |
| Total Current Assets | 9.9B | 10.0B | 9.9B | 10.3B | 10.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.7B | 1.8B | - | 1.7B | 1.6B |
| Goodwill | 21.1B | 23.7B | 22.9B | 24.0B | 24.9B |
| Intangible Assets | 2.6B | 3.0B | 3.2B | 3.5B | 3.7B |
| Long-term Investments | - | 8.0M | 3.0M | 4.0M | 2.0M |
| Other Non-Current Assets | 2.1B | 2.2B | 2.9B | 2.8B | 2.6B |
| Total Non-Current Assets | 17.0B | 19.0B | 19.5B | 20.4B | 20.6B |
| Total Assets | 26.9B | 29.0B | 29.4B | 30.7B | 31.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.9B | 1.8B | 1.9B | 2.0B | 1.9B |
| Short-term Debt | 1.0B | 443.0M | 654.0M | 325.0M | 310.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 321.0M | 211.0M | 147.0M | 933.0M | 396.0M |
| Total Current Liabilities | 7.5B | 8.1B | 8.3B | 7.9B | 7.4B |
| Non-Current Liabilities | |||||
| Long-term Debt | 6.8B | 7.0B | 7.0B | 7.0B | 5.7B |
| Deferred Tax Liabilities | 93.0M | 81.0M | 71.0M | 91.0M | 83.0M |
| Other Non-Current Liabilities | 44.0M | 44.0M | 57.0M | 60.0M | 55.0M |
| Total Non-Current Liabilities | 8.4B | 8.8B | 9.1B | 9.5B | 9.0B |
| Total Liabilities | 16.0B | 16.9B | 17.3B | 17.4B | 16.5B |
| Equity | |||||
| Common Stock | 193.0M | 188.0M | 183.0M | 178.0M | 177.0M |
| Retained Earnings | 3.6B | 3.6B | - | 6.8B | 9.3B |
| Treasury Stock | 298.0M | 411.0M | - | 275.0M | 476.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 11.0B | 12.0B | 12.1B | 13.3B | 14.5B |
| Key Metrics | |||||
| Total Debt | 7.8B | 7.5B | 7.6B | 7.3B | 6.0B |
| Working Capital | 2.4B | 1.9B | 1.7B | 2.3B | 2.9B |
Balance Sheet Composition
Koninklijke Philips Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 901.0M | -840.0M | -453.0M | -1.6B | 612.0M |
| Depreciation & Amortization | 1.1B | 1.4B | 1.3B | 1.6B | 1.3B |
| Stock-Based Compensation | 141.0M | 96.0M | 88.0M | 95.0M | 108.0M |
| Working Capital Changes | -1.2B | -94.0M | 1.3B | -1.1B | 13.0M |
| Operating Cash Flow | 1.5B | 1.8B | 2.4B | -1.0B | 1.9B |
| Investing Activities | |||||
| Capital Expenditures | 9.0M | 13.0M | 90.0M | 18.0M | 33.0M |
| Acquisitions | -25.0M | 118.0M | 7.0M | -588.0M | -3.0B |
| Investment Purchases | -113.0M | -123.0M | -138.0M | -188.0M | -124.0M |
| Investment Sales | 61.0M | 95.0M | 48.0M | 78.0M | 172.0M |
| Investing Cash Flow | -69.0M | 103.0M | 8.0M | -681.0M | -2.9B |
| Financing Activities | |||||
| Share Repurchases | 0 | -411.0M | -662.0M | -187.0M | -1.6B |
| Dividends Paid | -328.0M | -1.0M | -2.0M | -412.0M | -482.0M |
| Debt Issuance | 1.1B | 710.0M | 544.0M | 2.5B | 76.0M |
| Debt Repayment | -609.0M | -763.0M | -754.0M | -1.5B | -302.0M |
| Financing Cash Flow | 107.0M | -496.0M | -848.0M | 500.0M | -2.3B |
| Free Cash Flow | 504.0M | 893.0M | 1.5B | -979.0M | 866.0M |
| Net Change in Cash | 1.5B | 1.4B | 1.6B | -1.2B | -3.3B |
Cash Flow Trend
Koninklijke Philips Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
25.04
Forward P/E
13.61
Price to Book
2.02
Price to Sales
1.24
PEG Ratio
-0.12
Profitability Ratios
Profit Margin
5.02%
Operating Margin
10.73%
Return on Equity
7.82%
Return on Assets
3.20%
Financial Health
Current Ratio
1.32
Debt to Equity
73.57
Beta
0.96
Per Share Data
EPS (TTM)
€0.93
Book Value per Share
€11.52
Revenue per Share
€18.81
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PHIA | 22.2B | 25.04 | 2.02 | 7.82% | 5.02% | 73.57 |
| Galapagos NV | 1.6B | 5.10 | 0.50 | 10.42% | 28.85% | 0.21 |
| Pharming Group N.V | 1.0B | 57.15 | 4.31 | 1.02% | 0.76% | 41.78 |
| Vivoryon | 37.0M | -1.58 | 11.07 | -145.47% | 0.00% | 2.26 |
| ASML Holding N.V | 481.6B | 48.06 | 22.96 | 52.24% | 29.71% | 12.99 |
| Shell plc | 212.6B | 14.90 | 1.47 | 10.19% | 6.68% | 43.17 |
Financial data is updated regularly. All figures are in the company's reporting currency.